Aug 12, 2020
PDL BioPharma Enters Into Settlement Agreement with Wellstat
Apr 30, 2020
PDL BioPharma to Announce First Quarter 2020 Financial Results on May 7, 2020
Feb 28, 2020
PDL BioPharma Enters into Cooperation Agreement with Engine Capital
Feb 25, 2020
PDL BioPharma to Participate in the Cowen and Company 40th Annual Health Care Conference
Dec 19, 2019
PDL BioPharma Announces Upcoming Changes to its Board of Directors
Dec 16, 2019
PDL BioPharma Board of Directors Increases Share and Note Repurchase Authorization to $275 Million
Dec 13, 2019
PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024
Nov 14, 2019
PDL BioPharma Reaffirms Commitment To Shareholder Value Creation
Nov 06, 2019
PDL BioPharma Reports 2019 Third Quarter Financial Results
Oct 24, 2019
PDL BioPharma Responds to Letter from Engine Capital
Jul 31, 2019
PDL BioPharma to Announce Second Quarter 2019 Financial Results on August 7, 2019
Jun 25, 2019
PDL BioPharma Announces Departure of CFO
Jun 24, 2019
Natasha A. Hernday Elected to PDL BioPharma's Board of Directors
Jun 10, 2019
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
May 02, 2019
PDL BioPharma to Announce First Quarter 2019 Financial Results on May 9, 2019
Apr 16, 2019
PDL BioPharma to Hold Annual Meeting of Stockholders on June 20, 2019
Apr 11, 2019
Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma
Mar 14, 2019
PDL BioPharma Reports 2018 Fourth Quarter and Full Year Financial Results
Mar 12, 2019
PDL BioPharma to Participate at 31st Annual Roth Conference
Nov 06, 2018
PDL BioPharma Reports Third Quarter 2018 Financial Results